Dr. Prasad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
261 James Street
Suite 2G
Morristown, NJ 07960Phone+1 973-539-0333- Is this information wrong?
Summary
- Dr. Sandip Prasad is an urologist in Morristown, NJ and is affiliated with Morristown Medical Center. He received his medical degree from Duke University School of Medicine and has been in practice 12 years. He specializes in minimally invasive surgery, stone disease, and surgical oncology and is experienced in prostate cancer, gynecologic oncology, urologic oncology, minimally invasive urologic surgery, and urologic trauma and reconstructive surgery.
Education & Training
- Brigham and Women's Hospital/Harvard Medical SchoolResidency, Urology, 2006 - 2010
- Brigham and Womens HospitalInternship, Transitional Year, 2005 - 2006
- Duke University School of MedicineClass of 2005
- University of CambridgeMphil, Epidemiology, With Distinction, 1998 - 1999
- Harvard UniversityA.B., Environmental Science and Public Policy, Magna cum laude, 1994 - 1998
Certifications & Licensure
- NJ State Medical License 2017 - 2025
- SC State Medical License 2012 - 2017
- IL State Medical License 2010 - 2014
- MA State Medical License 2008 - 2010
- American Board of Urology Urology
Awards, Honors, & Recognition
- Merit Award ASCO Cancer Foundation, 2010
- Outstanding poster presentation American Urological Association, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- Editorial Comment.Gabriel Fernandez, Sandip M Prasad> ;Urology Practice. 2023 Nov 1
- Primary Chemoablation for Intermediate-Risk Low-Grade Bladder Cancer: New Paradigm or Added Uncertainty? Letter.Sandip M Prasad> ;The Journal of Urology. 2023 Dec 1
- 1 citationsTreatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection ...Sandip M Prasad, William C Huang, Neal D Shore, Brian Hu, Marc Bjurlin, Gordon Brown, Pencho Genov, Dimitar Shishkov, Alexandre Khuskivadze, Tosho Ganev, Dobri Marchev...> ;The Journal of Urology. 2023 Oct 1
- Join now to see all
Journal Articles
- Does robotic-assisted laparoscopic ileocystoplasty (RALI) reduce peritoneal adhesions compared to open surgeryRazmaria AA, Marchetti PE, Prasad SM, Shalhav AL, Gundeti MS, British Journal of Urology International, 1/1/2014
- Early discharge after laparoscopic or robotic partial nephrectomy: care pathway evaluationPatel A, Golan S, Razmaria A, Prasad S, Eggener S, Shalhav A, British Journal of Urology International, 1/1/2014
- Comparative effectiveness of minimally-invasive versus open lymphadenectomy in urological cancersPrasad SM, Shalhav AS, Current Opinion in Urology, 1/1/2013
- Join now to see all
Press Mentions
- 7 Studies at American Society of Clinical Oncology (ASCO) Annual Meeting Presented by Atlantic Health System Cancer Care Physician ResearchersJune 7th, 2021
- Prostate Cancer ADT Found to Increase Depression RiskApril 22nd, 2019
- hgGjkCOUotiIcDQwQtQOctober 12th, 2016
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
- Morristown Medical CenterMorristown, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: